Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001737287-25-000075
Filing Date
2025-06-23
Accepted
2025-06-23 21:03:43
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750727017.html 4  
1 FORM 4 wk-form4_1750727017.xml 4 4258
  Complete submission text file 0001737287-25-000075.txt   5669
Mailing Address 388 GREENWICH STREET, 17TH FLOOR NEW YORK NY 10013
Business Address
Humer Franz B (Reporting) CIK: 0001548072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 251066454

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)